Association between gene alterations and clinical response
tumor
TUMOR
We next sought to assess whether the response to combined therapy was associated with mutations in specific genes or pathways. The distribution of single-nucleotide variants associated with tumor response and survival outcome is depicted in Supplementary Table As an recent study demonstrated that loss-of-function mutations in chromatin remodeling genes may be associated with longer survival in patients with BTCs receiving chemo-immunotherapy